531726 Stock Overview
Engages in the manufacturing and trading of bulk drugs and intermediaries in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Panchsheel Organics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹277.15 |
| 52 Week High | ₹273.00 |
| 52 Week Low | ₹160.00 |
| Beta | 0.48 |
| 11 Month Change | 47.07% |
| 3 Month Change | 36.02% |
| 1 Year Change | 47.97% |
| 33 Year Change | 485.32% |
| 5 Year Change | 1,058.41% |
| Change since IPO | 13,757.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531726 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 9.7% | 2.2% | -1.0% |
| 1Y | 48.0% | 46.7% | 43.6% |
Return vs Industry: 531726 exceeded the Indian Pharmaceuticals industry which returned 46.7% over the past year.
Return vs Market: 531726 exceeded the Indian Market which returned 43.6% over the past year.
Price Volatility
| 531726 volatility | |
|---|---|
| 531726 Average Weekly Movement | 7.2% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.7% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 531726's share price has been volatile over the past 3 months.
Volatility Over Time: 531726's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 180 | Mahendra Turakhia | www.panchsheelorganics.com |
Panchsheel Organics Limited engages in the manufacturing and trading of bulk drugs and intermediaries in India. It manufactures and exports active pharma ingredients (API), human and veterinary intermediates and finished formulations, specialty chemicals, hormones, steroids, etc. The company also offers a range of products in various categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis, erectile dysfunction, and others. In addition, it provides over the counter products comprising healthcare and FMCG products, such as antibiotics, cough and cold remedies, pain relieve ranges, anti-inflammatory products, analgesics, protein health drinks, and contraceptives, as well as calcium, iron, and multivitamin supplements; veterinary medicines comprising APIs for animal health and feed supplements, disinfectants, and biologicals; pellets, direct compression granules, and taste masked granules; fitness and health care products; and nutraceuticals, as well as oncology products.
Panchsheel Organics Limited Fundamentals Summary
| 531726 fundamental statistics | |
|---|---|
| Market cap | ₹3.43b |
| Earnings (TTM) | ₹141.08m |
| Revenue (TTM) | ₹1.05b |
25.9x
P/E Ratio3.5x
P/S RatioIs 531726 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531726 income statement (TTM) | |
|---|---|
| Revenue | ₹1.05b |
| Cost of Revenue | ₹695.14m |
| Gross Profit | ₹357.04m |
| Other Expenses | ₹215.97m |
| Earnings | ₹141.08m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 10.71 |
| Gross Margin | 33.93% |
| Net Profit Margin | 13.41% |
| Debt/Equity Ratio | 5.0% |
How did 531726 perform over the long term?
See historical performance and comparison